「and areductionin」の検索結果
113件：26～30件目を表示
もしかして
-
Supplement business | Business Activities | About Senju | SENJU Pharmaceutical
Senju Pharmaceutical, as a pioneer of ophthalmic drugs, has long engaged in developing prescription and OTC drugs to contribute to the health of all people. As our next mission, we have found a way to...
https://www.senju.co.jp/english/about/business/ec.html -
学会发表 | 研究与开发 | 千寿制药株式会社
, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Development of...
https://www.senju.co.jp/chinese/rd/society/ -
nju”) hereby announces that it has started Phase III clinical trials in Japan for SJP-0049, a drug candidate for the treatment of allergic conjunctivitis, based on a compound licensed from Tanabe Phar...
https://www.senju.co.jp/system/files/content_news/2026-08/ENG_20260820_0.pdf -
千寿製薬株式会社
for the treatment of Allergic Conjunctivitis（PDF） June 1, 2026 Launch of Distribution of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Tre...
http://www.senju.co.jp/english/ -
学会发表 | 研究与开发 | 千寿制药株式会社
, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Development of...
http://www.senju.co.jp/chinese/rd/society/